Drug and device companies have just a month remaining to comment on a proposed rule that would require them to report all financial relationships with doctors.
As reported last year by MedPage Today and again Monday by the New York Times, the "Physician Payment Sunshine" provisions of the Affordable Care Act (ACA), require that drug, medical device, biologic, and medical equipment manufacturers that produce any products covered by Medicare or Medicaid or the Children's Health Insurance Program must report all payments made to doctors and hospitals.
The government will post the financial relationship information on a public website where patients and anyone else can check what ties to the medical industry a given doctor has.
The Centers for Medicare and Medicaid Services will accept comments on the proposal until Feb. 17, 2012, and will respond to them in a final rule to be published later this year.
Read the full story at:http://tinyurl.com/6motgc7
Source: MedPage Today
Switching to Gene Therapy After Nusinersen or Risdiplam May Benefit Patients With SMA
August 15th 2025Children with spinal muscular atrophy (SMA) showed motor function improvements after switching to onasemnogene abeparvovec following prior treatment with nusinersen or risdiplam in a real-world study.
Read More